Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Roehrs

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 25, 2020
BK polyomavirus nephropathy with systemic viral spread: Whole genome sequencing data from a fatal case of BKPyV infectionSanjeet Roy, Piotr A Mieczkowski, Carol Weida, et al.
The Journal of Nervous and Mental Disease|September 21, 2023
Terminal Lucidity in a Pediatric Oncology ClinicPhilip Roehrs, Peter Fenwick, Bruce Greyson, et al.
The Journal of Clinical Investigation|September 18, 2009
Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiencyAndrew L Snow, Rebecca A Marsh, Scott M Krummey, et al.
Orphanet Journal of Rare Diseases|April 26, 2025
Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH)Leonard Naymagon, Philip Roehrs, Michelle Hermiston, et al.
Blood|July 13, 2018
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficienciesCarl E Allen, Rebecca Marsh, Peter Dawson, et al.
Blood Advances|April 12, 2023
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCTAshley V Geerlinks, Brooks Scull, Christa Krupski, et al.
Blood Advances|February 11, 2021
A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplantChristopher E Dandoy, Seth Rotz, Priscila Badia Alonso, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 16, 2023
Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathyVandana Shashi, Kelly Schoch, Rebecca Ganetzky, et al.
The Journal of Clinical Investigation|June 12, 2018
Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiencyDavid Boutboul, Hye Sun Kuehn, Zoé Van de Wyngaert, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 25, 2020
BK polyomavirus nephropathy with systemic viral spread: Whole genome sequencing data from a fatal case of BKPyV infectionSanjeet Roy, Piotr A Mieczkowski, Carol Weida, et al.
The Journal of Nervous and Mental Disease|September 21, 2023
Terminal Lucidity in a Pediatric Oncology ClinicPhilip Roehrs, Peter Fenwick, Bruce Greyson, et al.
The Journal of Clinical Investigation|September 18, 2009
Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiencyAndrew L Snow, Rebecca A Marsh, Scott M Krummey, et al.
Orphanet Journal of Rare Diseases|April 26, 2025
Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH)Leonard Naymagon, Philip Roehrs, Michelle Hermiston, et al.
Blood|July 13, 2018
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficienciesCarl E Allen, Rebecca Marsh, Peter Dawson, et al.
Blood Advances|April 12, 2023
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCTAshley V Geerlinks, Brooks Scull, Christa Krupski, et al.
Blood Advances|February 11, 2021
A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplantChristopher E Dandoy, Seth Rotz, Priscila Badia Alonso, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 16, 2023
Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathyVandana Shashi, Kelly Schoch, Rebecca Ganetzky, et al.
The Journal of Clinical Investigation|June 12, 2018
Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiencyDavid Boutboul, Hye Sun Kuehn, Zoé Van de Wyngaert, et al.
Pageof 1